J. Horling et al., DETECTION AND SUBSEQUENT SEQUENCING OF PUUMALA-VIRUS FROM HUMAN SPECIMENS BY PCR, Journal of clinical microbiology, 33(2), 1995, pp. 277-282
A sensitive method based on PCR was developed for the detection of Puu
mala virus (PUU) in human samples. The assay was found to be specific
for PUU-like strains and distinguished between these and hantaviruses
of other serotypes. The detection limit was found to be 10(-5) focus-f
orming units. Clinical samples were collected from patients with nephr
opathia epidemica in Sweden and western Russia. Five whole blood sampl
es collected from patients in Russia with the acute phase of disease w
ere found to be positive by the PCR. AII samples were negative for PUU
antigen when examined by enzyme-linked immunosorbent assay. Virus iso
lation on Vero E6 cells from several of the acute-phase samples, inclu
ding,the 5 PCR-positive samples, was not successful. The amplified sam
ples were subjected to direct nucleic acid sequencing for confirmation
of identity. The sequences differed from each other and were closely
related to the Russian bank vole isolate CG-1820, thereby indicating t
he origin of nephropathia epidemica. The PCR was used for amplificatio
n and subsequent nucleotide sequencing of eight PUU-like isolates with
different geographic origins. The Swedish strains were more closely r
elated to the Finnish PUU prototype strain, Sotkamo, than to the Russi
an isolates. Interestingly, a Belgian isolate, CG-13891, differed mark
edly from all other PUU strains.